E-64
(Synonyms: N-(反式-环氧丁二酰基)-L-亮氨酸-4-胍基丁基酰胺,Proteinase inhibitor E 64) 目录号 : GC13418E-64是一种有效的不可逆的半胱氨酸蛋白酶抑制剂,对木瓜蛋白酶的IC50为9nM。
Cas No.:66701-25-5
Sample solution is provided at 25 µL, 10mM.
E-64 is a potent and irreversible inhibitor of cysteine proteases with an IC50 of 9nM for papain[1]. E-64 can inhibit the cysteine proteases cathepsin B, H, L and papain, but has no effect on serine proteases or metalloproteinases[2]. E-64 has antiparasitic activity in vitro and can induce oxidative stress and apoptosis in filarial parasites[3]. E-64 can improve the preimplantation development of bovine somatic cell nuclear transfer embryos[4].
In vitro, E-64 (0-50μM) treatment of breast cancer MDA-MB-231 cells for 24h increased the amount of intracellular active cathepsin S and reduced the amount of cathepsin L in a dose-dependent manner[5]. E-64 (4mM) treatment of porcine alveolar macrophages (PAM) for 48h upregulated the mRNA levels of IFNγ, IL-12 and IFN-α in cells without cytotoxicity[6].
In vivo, daily intravenous infusion of E-64 (1mg) in Dahl salt-sensitive rats significantly increased the mature forms of the lysosomal proteases Cath B and Cath L in the renal cortex of rats, but had no effect on high-salt diet-induced hypertension and renal damage[7].
References:
[1] Matsumoto K, Mizoue K, Kitamura K, et al. Structural basis of inhibition of cysteine proteases by E‐64 and its derivatives[J]. Peptide Science, 1999, 51(1): 99-107.
[2] Barrett A J, Kembhavi A A, Brown M A, et al. L-trans-Epoxysuccinyl-leucylamido (4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L[J]. Biochemical Journal, 1982, 201(1): 189-198.
[3] Wadhawan M, Singh N, Rathaur S. Inhibition of cathepsin B by E-64 induces oxidative stress and apoptosis in filarial parasite[J]. PLoS One, 2014, 9(3): e93161.
[4] Min S H, Song B S, Yeon J Y, et al. A cathepsin B inhibitor, E-64, improves the preimplantation development of bovine somatic cell nuclear transfer embryos[J]. Journal of Reproduction and Development, 2014, 60(1): 21-27.
[5] Wilder C L, Walton C, Watson V, et al. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells[J]. The international journal of biochemistry & cell biology, 2016, 79: 199-208.
[6] Liu B, Cui Y, Lu G, et al. Small molecule inhibitor E-64 exhibiting the activity against African swine fever virus pS273R[J]. Bioorganic & Medicinal Chemistry, 2021, 35: 116055.
[7] Blass G, Levchenko V, Ilatovskaya D V, et al. Chronic cathepsin inhibition by E‐64 in Dahl salt‐sensitive rats[J]. Physiological reports, 2016, 4(17): e12950.
E-64是一种有效的不可逆的半胱氨酸蛋白酶抑制剂,对木瓜蛋白酶的IC50为9nM[1]。E-64能够抑制半胱氨酸蛋白酶组织蛋白酶B、H、L和木瓜蛋白酶,但是对丝氨酸蛋白酶或金属蛋白酶没有作用[2]。E-64具有体外抗寄生虫活性,可以诱导丝虫寄生虫氧化应激和细胞凋亡[3]。E-64能够改善牛体细胞核移植胚胎的植入前发育[4]。
在体外,E-64(0-50μM)处理乳腺癌MDA-MB-231细胞24h,以剂量依赖性方式升高了细胞内活性组织蛋白酶S的量,减少了组织蛋白酶L的量[5]。E-64(4mM)处理猪肺泡巨噬细胞(PAM)48h,上调了细胞中IFNγ、IL-12和IFN-α的mRNA水平,且没有细胞毒性[6]。
在体内,E-64(1mg)通过每天静脉导管输注治疗Dahl盐敏感大鼠,显著增加了大鼠体内肾皮质成熟形式的溶酶体蛋白酶Cath B和Cath L,但是对高盐饮食诱导的高血压和肾损害没有效果[7]。
Cell experiment [1]: | |
Cell lines | MDA-MB-231 cells |
Preparation Method | Confluent MDA-MB-231 cells were treated with E-64 concentrations ranging from 0 to 50μM for 24h. Cells were lysed and subjected to multiplex cathepsin zymography to detect changes in the amount of active material. |
Reaction Conditions | 0-50μM; 24h |
Applications | E-64 treatment significantly increased the amount of active cathepsin S, while significantly decreased the amount of cathepsin L in cell lysates. |
Animal experiment [2]: | |
Animal models | Dahl Salt Sensitive rats (SS/JrHsdMcwi) |
Preparation Method | Dahl Salt Sensitive rats (SS/JrHsdMcwi) had their left femoral artery and vein catheterized. Both catheters were fixed and exteriorized from the back of the neck and the arterial line was connected to a heparinized saline infusion pump that was in line with a blood pressure transducer, and the venous line was connected to a saline infusion pump. Animals were allowed 360° movement using a tether-swivel system. A stable baseline blood pressure was obtained for 4 days prior to switching both groups to an 8.0% NaCl diet and the simultaneous addition of N-[N-(L-3-trans-carboxyox-irane-2-carbonyl)-L-leucyl]-agmatine (E-64, 1mg/day; 280mM stock in DMSO) or the vehicle control to the venous catheter. Daily mean arterial pressure (MAP) was calculated by averaging MAP taken every min over the beginning 3 h period of the rat sleep cycle. |
Dosage form | 1mg/day; i.v. |
Applications | A significant increase in the renal cortical mature form of Cath B and Cath L were measured in E-64 treated rats. |
References: [1]Wilder C L, Walton C, Watson V, et al. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells[J]. The international journal of biochemistry & cell biology, 2016, 79: 199-208. [2]Blass G, Levchenko V, Ilatovskaya D V, et al. Chronic cathepsin inhibition by E‐64 in Dahl salt‐sensitive rats[J]. Physiological reports, 2016, 4(17): e12950. |
Cas No. | 66701-25-5 | SDF | |
别名 | N-(反式-环氧丁二酰基)-L-亮氨酸-4-胍基丁基酰胺,Proteinase inhibitor E 64 | ||
化学名 | (2S,3S)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid | ||
Canonical SMILES | CC(C)CC(C(=O)NCCCCN=C(N)N)NC(=O)C1C(O1)C(=O)O | ||
分子式 | C15H27N5O5 | 分子量 | 357.41 |
溶解度 | ≥ 53.6mg/mL in DMSO | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.7979 mL | 13.9895 mL | 27.9791 mL |
5 mM | 0.5596 mL | 2.7979 mL | 5.5958 mL |
10 mM | 0.2798 mL | 1.399 mL | 2.7979 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet